|
SBI Symposium Collection: Challenging Breast Imaging Days Boot Camp

SBI Symposium Collection: Challenging Breast Imaging Days Boot Camp 

False positive and false negative findings contribute to limited sensitivity and specificity of breast imaging exams. Inappropriate characterization and usage of the BI-RADS assessment categories can contribute to inappropriate biopsies or missed breast cancers. Indeed, a recent study found the BI-RADS category 3 malignancy rate to be greater than the accepted limit of 2% for digital mammography. This activity aims to help radiologists gain clinical knowledge necessary to minimize false positive and false negative reads and increase diagnostic accuracy when interpreting mammograms, ultrasound, and MRI. This collection features presentations from the 2023 SBI Symposium.

CE Information

Earn up to 3.75 AMA PRA Category 1 Credits™ 

CME Released:  1/16/2024   CME Expires:  1/15/2027

ACCME Credit Designation Statement: Amedco LLC designates this live activity for a maximum of 3.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Challenging Breast Imaging Days Boot Camp Lectures

1) Calcifications: The Good, the Bad, and the Really Ugly

  • Elizabeth McDonald, MD, FSBI
  • Alison Chetlen, DO, FSBI

2) Distortions and Asymmetries: Detection, Management, and Biopsy

  • Liane Philpotts, MD, FSBI
  • Kimberly Ray, MD, FSBI
  • Shadi Shakeri, MD, FSBI

3) B3 or Not B3: That Is the Question

  • Ethan Cohen, MD, FSBI
  • Steven Poplack, MD, FSBI
  • Roberta Strigel, MD, FSBI

4) Bad Falsies: Minimizing FN and FP

  • Lars Grimm, MD, FSBI
  • Ana Lourenco, MD, FSBI
  • Habib Rahbar, MD, FSBI

 

Learner Notification:

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, and
complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You
must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty
not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your
licensing/certification requirement.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation Provider Number: 4008163

Physicians- ACCME Credit Designation Statement
Amedco LLC designates this material for a maximum of 3.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should
claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.

Name Commercial Interest - Relationship
Alison Chetlen- NA
Ethan Cohen- NA
Lars Grimm-Hologic:Consultant, Medscape Reference:Scientific/Medical Advisory Board Member
Ana Lourenco- NA
Elizabeth McDonald- NA
Liane Philpotts- NA
Steven Poplack- Johnson & Johnson, Merck Inc:Public Stock Shareholder
Habib Rahbar- Guerbet, LLC:Consultant
Kimberly Ray- NA
Shadi Shakeri- Siemens, BD, Izotropic:Consultant
Roberta Strigel- GE Healthcare:Other
Nuria Gramkee- NA
Ryan Dixon- NA

Course Objectives
  • Review differential diagnosis and management of calcifications in axillary lymph nodes
  • Identify strategies to minimize false positives and false negatives on mammography, US, and MRI
  • Define developing asymmetries and discuss appropriate management
  • Describe the appropriate management for architectural distortions
  • Discuss clinical scenarios not conducive to BI-RADS 3 assessments / short term imaging follow up
  • Describe the mammography, ultrasound, and breast MRI findings that may be appropriately assessed as BI-RADS 3
  • Discuss which calcification descriptors are appropriate for the BI-RADS 3 (probably benign) category and which are considered suspicious for malignancy
  • Describe the expected frequency of malignancy for BI-RADS 3 lesions
Breast Calcifications: The Good, the Bad, and the Really Ugly

Session Description: The presentations will review the appearance of benign versus malignant calcifications and discuss challenging cases.

Learning Objectives:

  1. Describe and recognize typically benign calcifications with the benign designation independent of distribution

  2. Describe and recognize calcifications that can safely be followed and how distribution impacts categorization for probably benign appearances.

  3. Describe and recognize calcifications that need to be sampled.

Speaker Information
Alison Chetlen DO, FSBI
Elizabeth McDonald MD, FSBI
Distortions and Asymmetries: Detection, Management, and Biopsy

Session Description: Three speakers will present a comprehensive review of detection, management, and biopsy of asymmetries and architectural distortions of the breast with particular emphasis on digital breast tomosynthesis. Attendees will be aware of the most recent literature and will gain confidence in their approach to these challenging lesions.

Learning Objectives:

  1. Better understand the significance of architectural distortion of the breast, particularly when found on digital breast tomosynthesis, and when to recommend biopsy.
  2. Identify and classify the different types of asymmetries and understand how they differ on 2D mammography versus DBT.
  3. Have greater confidence in the work up and biopsy of these lesions including determining concordance and further management.
Speaker Information
Liane Philpotts MD, FSBI
Kimberly Ray MD, FSBI
Shadi Shakeri MD, FSBI
B3 or Not B3: That Is the Question

Session Description: Review the appropriate use of BI-RADS assessment category 3 for mammography, breast ultrasound, and breast MRI.

Learning Objectives:

  1. Describe the frequency of BI-RADS assessment 3 for MRI, appropriate finding type/descriptors, and recommended follow-up.
  2. Describe the ultrasound findings that are appropriately assessed as a BI-RADS assessment category 3 (and a few that are more appropriately assessed as category 2 or 4).
  3. Distinguish clinical scenarios that are not conducive to short term follow up.
  4. Identify evidence based mammographic finding types that are appropriate for follow-up.
Speaker Information
Ethan Cohen MD, FSBI
Steven Poplack MD, FSBI
Roberta Strigel MD, FSBI
Bad Falsies: Minimizing FN and FP

Session Description: Far better than false nails or false lashes! Join us for a case based & interactive session where we will highlight best practices for minimizing both false positives and false negatives on mammography, ultrasound and MRI.

Learning Objectives:

  1. Identify and implement strategies to minimize false positives and negatives on mammography, US and MRI
  2. Describe common false negative imaging findings across the three modalities
  3. Analyze false positives on all modalities and approaches to minimize unnecessary biopsies
Speaker Information
Lars Grimm MD, FSBI
Ana Lourenco MD, FSBI
Habib Rahbar MD, FSBI
Individual topic purchase: Selected
AMEDCO
AMA PRA Category 1 Credit(s)™: 3.75
Breast Calcifications: The Good, the Bad, and the Really UglyDistortions and Asymmetries: Detection, Management, and Biopsy B3 or Not B3: That Is the Question Bad Falsies: Minimizing FN and FP
Preview
Preview Breast Calcifications: The Good, the Bad, and the Really UglyPreview Breast Calcifications: The Good, the Bad, and the Really Ugly
Products
SBI Symposium Collection: Challenging Breast Imaging Days Boot Camp
Member: $199.00
Non-Member Price: $299.00